SITE MAP  |  TERMS OF USE  |  © 2013 RHYTHM PHARMACEUTICALS
Overview
Management
Board of Directors
Scientific Advisory Board
Investors
INVESTORS
Rhythm has raised a total of $73 million in two rounds of equity financing. Investors include MPM Capital, New Enterprise Associates, Third Rock Ventures, Ipsen, and Pfizer Venture Investments.


Ipsen
  •   ABOUT RHYTHM  
    • Corporate Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  •   PROGRAMS  
    • Technology: Peptide Therapeutics
    • Focus
    •        Obesity & Diabetes
    •        GI Functional Disorders
    • Pipeline
    •        Ghrelin: RM-131
    •        MC4: RM-493
  •   NEWS & RESOURCES  
    • Press Releases
    • Published Research
  •   CONTACT
    • Contact Rhythm
    • Directions